Articles citing this paper
cfArticle2ecfc1291681887$funcTITLE@473831c2
Dorota M. Gertig A , Julia M. L. Brotherton A B and Marion Saville A
+ Author Affiliations
- Author Affiliations
A Victorian Cytology Service, PO Box 161, Carlton South, Vic. 3053, Australia.
B Corresponding author. Email: jbrother@vcs.org.au
Sexual Health 8(2) 171-178 https://doi.org/10.1071/SH10001
Submitted: 4 January 2010 Accepted: 21 May 2010 Published: 18 May 2011
75 articles found in Crossref database.
Decline in in-patient treatments of genital warts among young Australians following the national HPV vaccination program
Ali Hammad,
Guy Rebecca J,
Wand Handan,
Read Tim RH,
Regan David G,
Grulich Andrew E,
Fairley Christopher K, Donovan Basil
BMC Infectious Diseases. 2013 13(1).
Cervical screening in HPV-vaccinated populations
Canfell K.
Climacteric. 2018 21(3). p.227
Utility of reports and routine correspondence from the National HPV Vaccination Program Register
Brotherton Julia M L,
Batchelor Michael, Winch Karen
Medical Journal of Australia. 2013 199(7). p.463
Parental and societal support for adolescent immunization through school based immunization programs
Marshall Helen S.,
Collins Joanne,
Sullivan Thomas,
Tooher Rebecca,
O’Keefe Maree,
Skinner S. Rachel,
Watson Maureen,
Burgess Teresa,
Ashmeade Heather, Braunack-Mayer Annette
Vaccine. 2013 31(30). p.3059
Barriers to better three‐dose coverage with HPV vaccination in school‐based programs
Watson Maureen,
Lynch John,
D'Onise Katina, Brotherton Julia
Australian and New Zealand Journal of Public Health. 2014 38(1). p.91
Modeling Preventative Strategies against Human Papillomavirus-Related Disease in Developed Countries
Canfell Karen,
Chesson Harrell,
Kulasingam Shalini L.,
Berkhof Johannes,
Diaz Mireia, Kim Jane J.
Vaccine. 2012 30 p.F157
Prevalence of human papillomavirus in teenage heterosexual males following the implementation of female and male school-based vaccination in Australia: 2014–2017
Chow Eric P.F.,
Tabrizi Sepehr N.,
Fairley Christopher K.,
Wigan Rebecca,
Machalek Dorothy A.,
Regan David G.,
Hocking Jane S.,
Garland Suzanne M.,
Cornall Alyssa M.,
Atchison Steph,
Bradshaw Catriona S.,
McNulty Anna,
Owen Louise,
Marshall Lewis,
Russell Darren B.,
Kaldor John M., Chen Marcus Y.
Vaccine. 2019 37(46). p.6907
Abeloff's Clinical Oncology (2020)
Measuring effectiveness of the cervical cancer vaccine in an Australian setting (the VACCINE study)
Young Elisa J,
Tabrizi Sepehr N,
Brotherton Julia ML,
Wark John D,
Pyman Jan,
Saville Marion,
Wrede C David,
Jayasinghe Yasmin,
Tan Jeffrey,
Gertig Dorota M,
Pitts Marian, Garland Suzanne M
BMC Cancer. 2013 13(1).
Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study
Tabrizi Sepehr N,
Brotherton Julia M L,
Kaldor John M,
Skinner S Rachel,
Liu Bette,
Bateson Deborah,
McNamee Kathleen,
Garefalakis Maria,
Phillips Samuel,
Cummins Eleanor,
Malloy Michael, Garland Suzanne M
The Lancet Infectious Diseases. 2014 14(10). p.958
Human Papillomavirus Type 6 and 11 Genetic Variants Found in 71 Oral and Anogenital Epithelial Samples from Australia
Danielewski Jennifer A.,
Garland Suzanne M.,
McCloskey Jenny,
Hillman Richard J.,
Tabrizi Sepehr N., Burk Robert D.
PLoS ONE. 2013 8(5). p.e63892
Aggregation and Competitive Exclusion: Explaining the Coexistence of Human Papillomavirus Types and the Effectiveness of Limited Vaccine Conferred Cross-Immunity
Waters E. K.
Acta Biotheoretica. 2012 60(4). p.333
HPV vaccination in women treated for CIN2/3: It's still all about prevention
Huh Warner K.
Gynecologic Oncology. 2013 130(2). p.255
Fall in Human Papillomavirus Prevalence Following a National Vaccination Program
Tabrizi S. N.,
Brotherton J. M. L.,
Kaldor J. M.,
Skinner S. R.,
Cummins E.,
Liu B.,
Bateson D.,
McNamee K.,
Garefalakis M., Garland S. M.
Journal of Infectious Diseases. 2012 206(11). p.1645
Implementation of the quadrivalent vaccine against HPV in the Municipality of Campos dos Goytacazes, Brazil – A combination of strategies to increase immunization coverage and early reduction of genital warts
Kury Charbell M.H.,
Kury Marcus M.H.,
Silva Raquel M.H.,
Oliveira Francisco A.S.,
de Moraes José C.,
De Moraes Juliana G.S.A.,
Pereira Christiane C.R., Vieira Bianca S.
Trials in Vaccinology. 2013 2 p.19
Prophylactic papillomavirus vaccines
Ribeiro-Müller Lis, Müller Martin
Clinics in Dermatology. 2014 32(2). p.235
Ethical Challenges in School-Based Immunization Programs for Adolescents: A Qualitative Study
Braunack-Mayer Annette,
Skinner S. Rachel,
Collins Joanne,
Tooher Rebecca,
Proeve Claudia,
O’Keefe Maree,
Burgess Teresa,
Watson Maureen, Marshall Helen
American Journal of Public Health. 2015 105(7). p.1399
The Australian Experience With the Human Papillomavirus Vaccine
Garland Suzanne M.
Clinical Therapeutics. 2014 36(1). p.17
Looking beyond human papillomavirus (HPV) genotype 16 and 18: Defining HPV genotype distribution in cervical cancers in Australia prior to vaccination
Brotherton Julia M.L.,
Tabrizi Sepehr N.,
Phillips Samuel,
Pyman Jan,
Cornall Alyssa M.,
Lambie Neil,
Anderson Lyndal,
Cummings Margaret,
Payton Diane,
Scurry James P.,
Newman Marsali,
Sharma Raghwa,
Saville Marion, Garland Suzanne M.
International Journal of Cancer. 2017 141(8). p.1576
A revision of sexual mixing matrices in models of sexually transmitted infection
Walker Robert,
Nickson Carolyn,
Lew Jie‐Bin,
Smith Megan, Canfell Karen
Statistics in Medicine. 2012 31(27). p.3419
Adolescent and young adult HPV vaccination in Australia: Achievements and challenges
Garland Suzanne M.,
Skinner S. Rachel, Brotherton Julia M.L.
Preventive Medicine. 2011 53 p.S29
Effectiveness of HPV vaccine by age at vaccination and number of doses: protocol for a population-based matched case–control study
Oliveira Carlos R,
Ortiz Anette Michelle,
Sheth Sangini S,
Shapiro Eugene D, Niccolai Linda M
BMJ Open. 2021 11(4). p.e043093
Towards the eradication of HPV infection through universal specific vaccination
Crosignani Piergiorgio,
De Stefani Antonella,
Fara Gaetano Maria,
Isidori Andrea M,
Lenzi Andrea,
Liverani Carlo Antonio,
Lombardi Alberto,
Mennini Francesco Saverio,
Palu’ Giorgio,
Pecorelli Sergio,
Peracino Andrea P,
Signorelli Carlo, Zuccotti Gian Vincenzo
BMC Public Health. 2013 13(1).
Addressing HPV vaccine myths: practical information for healthcare providers
Bednarczyk Robert A.
Human Vaccines & Immunotherapeutics. 2019 15(7-8). p.1628
Temporal Trends in Population-Level Cure of Cancer: The Australian Context
Kou Kou,
Dasgupta Paramita,
Cramb Susanna M.,
Yu Xue Qin, Baade Peter D.
Cancer Epidemiology, Biomarkers & Prevention. 2020 29(3). p.625
Cervical screening rates for women vaccinated against human papillomavirus
Budd Alison C,
Brotherton Julia M L,
Gertig Dorota M,
Chau Theresa,
Drennan Kelly T, Saville Marion
Medical Journal of Australia. 2014 201(5). p.279
Induction of cross‐neutralizing antibodies by sequential immunization with heterologous papillomavirus L1VLPs and its implications for HPV prophylactic vaccines
Zhang Ting,
Chen Xue,
Liao Guoyang,
Hu Meili,
Xu Jianqing, Xu Xuemei
Journal of Medical Virology. 2020 92(12). p.3750
HPV vaccine coverage is increasing in Australia
Brotherton Julia ML,
Winch Karen L,
Bicknell Lisette,
Chappell Genevieve, Saville Marion
Medical Journal of Australia. 2017 206(6). p.262
Cost-effectiveness and equity impacts of three HPV vaccination programmes for school-aged girls in New Zealand
Blakely Tony,
Kvizhinadze Giorgi,
Karvonen Tanja,
Pearson Amber L.,
Smith Megan, Wilson Nick
Vaccine. 2014 32(22). p.2645
Accuracy of Self-reported Human Papillomavirus Vaccination Status Among Gay and Bisexual Adolescent Males: Cross-sectional Study
Chow Eric PF,
Fairley Christopher K,
Wigan Rebecca,
Hocking Jane S,
Garland Suzanne M,
Cornall Alyssa M,
Tabrizi Sepehr N, Chen Marcus Y
JMIR Public Health and Surveillance. 2021 7(12). p.e32407
Human papillomavirus 16/18 seroprevalence in unvaccinated women over 30 years with normal cytology and with high grade cervical abnormalities in Australia: results from an observational study
Velentzis Louiza S,
Sitas Freddy,
O’Connell Dianne L,
Darlington-Brown Jessica,
Egger Sam,
Sinha Rohit,
Banks Emily,
Frazer Ian H, Canfell Karen
BMC Infectious Diseases. 2014 14(1).
Annual Immunisation Coverage Report 2017
Hull Brynley,
Hendry Alexandra,
Dey Aditi,
Brotherton Julia,
Macartney Kristine, Beard Frank
Communicable Diseases Intelligence. 2019 43
Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study
Brotherton Julia ML,
Fridman Masha,
May Cathryn L,
Chappell Genevieve,
Saville A Marion, Gertig Dorota M
The Lancet. 2011 377(9783). p.2085
Estimating human papillomavirus vaccination coverage among young women in Victoria and reasons for non-vaccination
Brotherton Julia M. L.,
Piers Leonard S., Vaughan Loretta
Sexual Health. 2016 13(2). p.190
HPV vaccine for men: Where to? (Review)
Spînu Arsenie,
Anghel Radu,
Marcu Dragoș,
Iorga Daniel,
Cherciu Alexandru, Mischianu Dan
Experimental and Therapeutic Medicine. 2021 22(5).
Parents’ Recall and Reflections on Experiences Related to HPV Vaccination for Their Children
Niccolai Linda M.,
Hansen Caitlin E.,
Credle Marisol, Shapiro Eugene D.
Qualitative Health Research. 2016 26(6). p.842
The effect of making a ‘third dose assumption’ on HPV coverage estimates
Brotherton Julia M., Winch Karen
Australian and New Zealand Journal of Public Health. 2015 39(2). p.193
HPV vaccination coverage: slightly improved two‐dose schedule completion estimates and historical estimates lower on AIR than HPV Register
Brotherton Julia,
Hendry Alexandra,
Dey Aditi,
Hull Brynley P., Beard Frank
Australian and New Zealand Journal of Public Health. 2022 46(3). p.394
Genital warts are more than an inconvenience!
Garland S.M.,
Pirotta M., Donovan B.
Public Health. 2012 126(6). p.546
Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study
Gertig Dorota M,
Brotherton Julia ML,
Budd Alison C,
Drennan Kelly,
Chappell Genevieve, Saville A Marion
BMC Medicine. 2013 11(1).
Development of a quality framework for models of cervical screening and its application to evaluations of the cost-effectiveness of HPV vaccination in developed countries
Simonella Leonardo, Canfell Karen
Vaccine. 2015 33(1). p.34
Immunisation coverage annual report, 2015
Hull Brynley,
Hendry Alexandra,
Dey Aditi,
Beard Frank,
Brotherton Julia, McIntyre Peter
Communicable Diseases Intelligence. 2019 43
Measuring HPV vaccination coverage in Australia: comparing two alternative population‐based denominators
Barbaro Bianca, Brotherton Julia M.L.
Australian and New Zealand Journal of Public Health. 2015 39(4). p.326
Controversies in the Management of Gynecological Cancers (2014)
Cervical Cancer Burden and Prevention Strategies: Asia Oceania Perspective
Garland Suzanne M.,
Bhatla Neerja, Ngan Hextan Y.S.
Cancer Epidemiology, Biomarkers & Prevention. 2012 21(9). p.1414
Estimates of the timing of reductions in genital warts and high grade cervical intraepithelial neoplasia after onset of human papillomavirus (HPV) vaccination in the United States
Chesson Harrell W.,
Ekwueme Donatus U.,
Saraiya Mona,
Dunne Eileen F., Markowitz Lauri E.
Vaccine. 2013 31(37). p.3899
Will vaccinated women attend cervical screening? A population based survey of human papillomavirus vaccination and cervical screening among young women in Victoria, Australia
Brotherton Julia M.L., Mullins Robyn M.
Cancer Epidemiology. 2012 36(3). p.298
Monitoring HPV Vaccine Impact: Early Results and Ongoing Challenges
Hariri S., Markowitz L.
Journal of Infectious Diseases. 2012 206(11). p.1633
Development of promising interventions to improve human papillomavirus vaccination in the school-based program in Quebec, Canada: results from a formative evaluation. (Preprint)
Dionne Maude,
Sauvageau Chantal,
Etienne Doriane,
Kiely Marilou,
Witteman Holly, Dubé Eve
JMIR Formative Research. 2024
Herd immunity effect of the HPV vaccination program in Australia under different assumptions regarding natural immunity against re-infection
Korostil Igor A.,
Peters Gareth W.,
Law Matthew G., Regan David G.
Vaccine. 2013 31(15). p.1931
Assessing HPV vaccine coverage in Australia by geography and socioeconomic status: are we protecting those most at risk?
Barbaro Bianca, Brotherton Julia M.L.
Australian and New Zealand Journal of Public Health. 2014 38(5). p.419
Attitudes, Knowledge and Factors Associated with Human Papillomavirus (HPV) Vaccine Uptake in Adolescent Girls and Young Women in Victoria, Australia
Tung Iris L. Y.,
Machalek Dorothy A.,
Garland Suzanne M., Consolaro Marcia Edilaine Lopes
PLOS ONE. 2016 11(8). p.e0161846
Potential of the quadrivalent human papillomavirus vaccine in the prevention and treatment of cervical cancer
Garland Suzanne M, Brown Darron R
Expert Opinion on Biological Therapy. 2014 14(4). p.527
Near Elimination of Genital Warts in Australia Predicted With Extension of Human Papillomavirus Vaccination to Males
Korostil Igor A.,
Ali Hammad,
Guy Rebecca J.,
Donovan Basil,
Law Matthew G., Regan David G.
Sexually Transmitted Diseases. 2013 40(11). p.833
Human papilloma virus vaccination: impact and recommendations across the world
Bonanni Paolo,
Bechini Angela,
Donato Rosa,
Capei Raffaella,
Sacco Cristiana,
Levi Miriam, Boccalini Sara
Therapeutic Advances in Vaccines. 2015 3(1). p.3
Human papillomavirus vaccine trials and tribulations
Handler Nancy S.,
Handler Marc Z.,
Majewski Slawomir, Schwartz Robert A.
Journal of the American Academy of Dermatology. 2015 73(5). p.759
Reaching 80% human papillomavirus vaccination prevalence by 2026: How many adolescents need to be vaccinated and what are their characteristics?
Fedewa Stacey A.,
Preiss Alexander J.,
Fisher‐Borne Marcie,
Goding Sauer Ann,
Jemal Ahmedin, Saslow Debbie
Cancer. 2018 124(24). p.4720
Human papillomavirus vaccine coverage among female Australian adolescents: success of the school‐based approach
Brotherton Julia M L,
Murray Sharron L,
Hall Madeline A,
Andrewartha Lynne K,
Banks Carolyn A,
Meijer Dennis,
Pitcher Helen C,
Scully Megan M, Molchanoff Luda
Medical Journal of Australia. 2013 199(9). p.614
Human papillomavirus vaccination and genital warts in young Indigenous Australians: national sentinel surveillance data
Ali Hammad,
McManus Hamish,
O'Connor Catherine C,
Callander Denton,
Kong Marlene,
Graham Simon,
Saulo Dina,
Fairley Christopher K,
Regan David G,
Grulich Andrew,
Low Nicola,
Guy Rebecca J, Donovan Basil
Medical Journal of Australia. 2017 206(5). p.204
Australia's contribution to global immunisation
Ruff Tilman A.,
Taylor Kate, Nolan Terry
Australian and New Zealand Journal of Public Health. 2012 36(6). p.564
Human papillomavirus vaccination: Where are we now?
Brotherton Julia ML
Journal of Paediatrics and Child Health. 2014 50(12). p.959
Parents' views on human papillomavirus vaccination for sexually transmissible infection prevention: a qualitative study
Niccolai Linda M.,
Hansen Caitlin E.,
Credle Marisol,
Ryan Sheryl A., Shapiro Eugene D.
Sexual Health. 2014 11(3). p.274
Annual Immunisation Coverage Report 2016
Hull Brynley,
Hendry Alexandra,
Dey Aditi,
Beard Frank,
Brotherton Julia, McIntyre Peter
Communicable Diseases Intelligence. 2019 43
Very Low Prevalence of Vaccine Human Papillomavirus Types Among 18- to 35-Year Old Australian Women 9 Years Following Implementation of Vaccination
Machalek Dorothy A,
Garland Suzanne M,
Brotherton Julia M L,
Bateson Deborah,
McNamee Kathleen,
Stewart Mary,
Rachel Skinner S,
Liu Bette,
Cornall Alyssa M,
Kaldor John M, Tabrizi Sepehr N
The Journal of Infectious Diseases. 2018 217(10). p.1590
Human Papillomavirus and Oropharyngeal Cancer Among Indigenous Australians: Protocol for a Prevalence Study of Oral-Related Human Papillomavirus and Cost-Effectiveness of Prevention
Jamieson Lisa,
Garvey Gail,
Hedges Joanne,
Mitchell Amanda,
Dunbar Terry,
Leane Cathy,
Hill Isaac,
Warren Kate,
Brown Alex,
Ju Xiangqun,
Roder David,
Logan Richard,
Johnson Newell,
Smith Megan,
Antonsson Annika, Canfell Karen
JMIR Research Protocols. 2018 7(6). p.e10503
Risk factors for the development and severity of juvenile-onset recurrent respiratory papillomatosis: A systematic review
Niyibizi Joseph,
Rodier Caroline,
Wassef Maggy, Trottier Helen
International Journal of Pediatric Otorhinolaryngology. 2014 78(2). p.186
Bug Breakfast in the Bulletin: The early impact of the National HPV Vaccination Program
Quinn Emma,
Donovan Basil, Sheppeard Vicky K.
New South Wales Public Health Bulletin. 2012 23(10). p.208
Testing previous model predictions against new data on human papillomavirus vaccination program outcomes
Smith Megan A, Canfell Karen
BMC Research Notes. 2014 7(1).
Characteristics of a cluster-randomized phase IV human papillomavirus vaccination effectiveness trial
Lehtinen Matti,
Apter Dan,
Baussano Iacopo,
Eriksson Tiina,
Natunen Kari,
Paavonen Jorma,
Vänskä Simopekka,
Bi Dan,
David Marie-Pierre,
Datta Sanjoy,
Struyf Frank,
Jenkins David,
Pukkala Eero,
Garnett Geoff, Dubin Gary
Vaccine. 2015 33(10). p.1284
Associations Between Exposure to and Expression of Negative Opinions About Human Papillomavirus Vaccines on Social Media: An Observational Study
Dunn Adam G,
Leask Julie,
Zhou Xujuan,
Mandl Kenneth D, Coiera Enrico
Journal of Medical Internet Research. 2015 17(6). p.e144
The potential impact of HPV-16 reactivation on prevalence in older Australians
Korostil Igor A, Regan David G
BMC Infectious Diseases. 2014 14(1).
Assessing genital human papillomavirus genoprevalence in young Australian women following the introduction of a national vaccination program
Osborne Sarah L.,
Tabrizi Sepehr N.,
Brotherton Julia M.L.,
Cornall Alyssa M.,
Wark John D.,
Wrede C. David,
Jayasinghe Yasmin,
Gertig Dorota M.,
Pitts Marian K., Garland Suzanne M.
Vaccine. 2015 33(1). p.201
HPV genotype prevalence in Australian women undergoing routine cervical screening by cytology status prior to implementation of an HPV vaccination program
Tabrizi Sepehr N.,
Brotherton Julia M.L.,
Stevens Matthew P.,
Condon John R.,
McIntyre Peter,
Smith David, Garland Suzanne M.
Journal of Clinical Virology. 2014 60(3). p.250
Immunoprevention of Human Papillomavirus–Associated Malignancies
Wang Joshua W.,
Hung Chein-fu,
Huh Warner K.,
Trimble Cornelia L., Roden Richard B.S.
Cancer Prevention Research. 2015 8(2). p.95
Human papillomavirus (HPV) vaccination coverage in young Australian women is higher than previously estimated: Independent estimates from a nationally representative mobile phone survey
Brotherton Julia M.L.,
Liu Bette,
Donovan Basil,
Kaldor John M., Saville Marion
Vaccine. 2014 32(5). p.592
